Genmab | Capital De Empréstimo



Loan Capital Alterar Data
Agios Pharmaceuticals USD 0 0 2024-12
Almirall EUR 351.76M 538K 2024-06
Amarin USD 0 0 2024-09
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Bayer EUR 34.55B 2.12B 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Demant DKK 14.59B 1.4B 2024-12
Exelixis USD 0 0 2025-01
Fresenius Medical Care EUR 9.76B 202.37M 2024-12
Galapagos EUR 8.24M 1000K 2024-12
Genmab DKK 937M 41M 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
GN Store Nord DKK 9.4B 5.1B 2024-12
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Insmed USD 1.13B 147.77M 2024-12
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.37B 1.51B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
UCB EUR 2.82B 166M 2024-12



Genmab Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.